Back in 2023, Withings launched Body Scan, a super-premium scale with the sort of tech found in a high-end gym or low-end clinic. It had a six-lead ECG, offered segmented body composition and could monitor your nerve health, among other things. Now the company has rocked up at CES 2026 in Las Vegas with a second-generation model that adds in tests for hypertension and cellular health. Withings hopes the new model will give you even more data you can use to fight against chronic illnesses brought on by our decadent modern lifestyle.
The first generation Body Scan checked 40 biomarkers, while the new model has 60, and even the press materials need a bulleted list to talk about the new features. Topping the bill is the new Impedance Cardiography (ICG) which monitors your heart’s capacity to pump blood to the organs. Second, Bioimpedance Spectroscopy (BIS) uses a low level electrical current to check your body’s total water, letting the scale keep an eye on your cellular age, active cell mass and metabolic efficiency.
Naturally, all of this data will then be extruded through the company’s “clinically validated” AI model to offer more insights, such as your risk of hypertension and glycemic regulation. You’ll also be told, based on your vital statistics, your health trajectory, and given tips on how to improve your “healthspan.” In short, the company wants to further position this as a clinic in a box, steering you toward healthier choices as and when it can.
There’s one major hardware tweak from the first generation, as the retractable handle used for the ECG now contains the scale’s display. That, I’m sure, makes it easier to read if you’re squinting naked onto the scale after your morning shower. But I’m also concerned that it’s a single point of failure for the thin cable attaching the handle to the rest of the scale.
Withings hopes to get the Body Scan 2 cleared by the FDA in time for its planned launch in the second quarter of 2026. As for the price, expect to pay a pretty penny for the flagship gear, as it will set you back $599.95, €499.95 or £449.95, depending on your territory.
It’s been nearly three years since Withings first showed off U-Scan to a bemused world, and now it’s finally on sale. U-Scan is the company’s at-home urinalysis gizmo which sits in your toilet bowl and tests your first splash of the day. The device runs a tiny sample through a microfluidic to test, depending on what cartridge you use, either your nutritional or kidney health. These results are then sent to the Withings app, letting you track the quality of your urine over time. Your humble narrator holds the dubious honor of being the first reporter to test the U-Scan during its debut, and found the results pretty interesting.
There are two cartridges available at launch, the first dubbed Nutrio, which looks at your body’s response to nutrition. It will look at your urine’s pH, specific gravity, ketones and the presence of vitamin C over time. Those factors can help you understand if your diet is too acidic, how much fluid you’re drinking on a regular basis, if you’re burning fat, and your anti oxidant intake. The company says that Nutri will be of special interest to people taking GLP-1 medication for weight loss to help them monitor changes to their nutrition levels. Calci, meanwhile, will track your urine’s pH, specific gravity and calcium levels, to keep an eye on your risk of developing kidney stones.
Naturally, such a tool will not be the most affordable in the world, and you can expect to pay a hefty price to own one. Pay $379.95 and you’ll be able to get a U-Scan, a single cartridge that will last for three months, and access to Withings+. The options are then split across “Proactive” and “Intensive” Plans, with the former giving you 2-4 analyses per week, while the latter runs near-daily. If you want the closer monitoring, then $449.96 will get you two cartridges and Withings+ access, which will last you the same three month window. As for replacement cartridges, those on the Proactive tier will spend $99.95 every quarter, while those in team Intensive will pay $179.95. As part of signing up for Withings+, you’ll get a free coaching session with a registered dietician available in all 50 states.
Withings, which is best known for its smart scales and similar devices, also makes a smartwatch series, the latest of which is the ScanWatch 2. At IFA 2025, the company announced a new blue and silver version of the 42mm model. It also unveiled HealthSense 4, an AI-laden software update that leverages the tech to handle a set of new health- and sleep-tracking features.
I grabbed a picture of the ScanWatch 2 while I was there, and now I get the appeal of this watch. If you’re not familiar, the ScanWatch’s big deal is that they’re like smartwatches disguised as regular old analog watches, complete with mechanical time-telling hands and a more standard overall watch face. The screen itself is just a watch face complication—a tiny circle embedded in the upper part of the screen. The ScanWatch 2 looks nice, and the blue-banded, silver model is no different. In fact, I’m a fan of the blue, if only because it reminds me of the blue suit Adam Sandler wears throughout the movie Punch Drunk Love. (If you haven’t seen it and you’re scoffing at an Adam Sandler mention in this Very Serious Smartwatch Article, cut it out, and go watch the movie.)
This version of the ScanWatch 2 is available now on Withings’s website, Amazon, Target, and Best Buy, and costs $369.95. Buyers will get a month of Withings Plus for free. (After that, it’s $9.95 a month, or $99.50 per year.)
Under the hood, the ScanWatch 2 does a lot of what other, more conspicuous smartwatches do. It takes measurements of things like heart rate and blood oxygen level, or carries out ECG readings to power atrial fibrillation detection.
With HealthSense 4, the ScanWatch 2 (and ScanWatch Nova and Nova Brilliant, but not the original ScanWatch or ScanWatch Light) can now track REM sleep and take more accurate measurements of your breathing rhythm while you sleep. Withings says its new algorithms, using data gathered by the smartwatch—such as heart rate variability, physical activity, body temperature, and respiratory rhythm—can find possible causes of fatigue, and provide AI-powered recommendations telling users what they might be able to do to feel less tired all the time. These recommendations are collected under what Withings calls the Vitality Indicator, which you need a Withings Plus subscription to access on your phone.
Withings product manager Etienne Tregaro walked me through some of the new app features at IFA 2025. The Vitality Indicator screen gives you an overview of your “vitality,” which I took to be a sort of shorthand for Withings’ AI system’s impression of your overall readiness to face a given day. Days of the week at the top of the screen are filled with circles with green outlines that can be anywhere from nonexistent to a complete ring—the fuller the ring, the less fatigued you are. At the bottom, various boxes tell you where you are for the day in categories like Recovery and Effort.
The Withings app also features Withings Intelligence—a chatbot you can talk to about your health metrics. It can take note of patterns; another Withings representative I spoke with showed me a screen where the chatbot noted he had just lost a little weight, speculated about the causes, and asked if he’d been intentionally trying to lose weight. In theory, it would give him helpful guidance, depending on his answer.
The subscription also gives access to AI-powered notifications letting users know when their menstrual cycle is beginning or when the ScanWatch 2 has picked up signs of an infection. The Withings Plus service also comes with Cardio Check-Up, an option to have your cardiovascular data checked by a professional cardiologist, who returns a basic summary of what they saw and recommendations for dealing with issues that may have cropped up.
It’s a staggering update that leapfrogs over Apple’s more passive presentation of health information and more closely mirrors efforts by companies like Samsung to deploy AI, informed by smart wearables data, as a health coach. I worry it could draw certain people further into unhealthy obsessions with constantly tracking and micromanaging their health? I’m not an expert in this; for that, I’d encourage you to read the manyarticleson the subject. We’re riding into a new frontier with generative AI now becoming more deeply enmeshed in smart wearables, and only time will tell.
One thing you won’t need a subscription for is the battery life improvement that comes with the new HealthSense4 software. Now, the ScanWatch 2 gets 35 days on a charge, which is up from 30 days before, already way more battery life than most standard smartwatches. Although to get there, you’ll probably need to turn off a number of the ScanWatch 1’s features, like its always-on display or blood oxygen sensor.
Tregaro told me Withings managed to add those days by identifying areas it could optimize its code. I asked what your settings would have to look like to actually reach 35 days on a charge, because obviously you can’t expect that while using every single feature the ScanWatch 2 offers. He said you’d need to turn off a number of features, including some of the overnight tracking or notifications. Withings, to its credit, has a chart that can tell you which features incur the biggest battery life penalty. Nice to have a guide.
Withings is announcing the ScanWatch Nova Brilliant, a 39mm version of its smartwatch. It comes in titanium silver and a two-tone silver and gold. For those with smaller wrists, this watch should be a more comfortable fit than the standard 42mm option.
The elegant timepiece mixes analog features with modern digital ones. A small OLED screen on the top half of the watch helps you tell the time quickly and can also display health metrics, but there are mechanical hands for a classic look. It’s also water resistant up to 50 meters (5 ATM) and has a five-link stainless steel bracelet for improved outdoor durability. The battery lasts for 30 days but there’s no info about the charging time.
Withings outfitted this smartwatch with a medical-grade electrocardiogram to check your heartbeat for irregularities. The watch can also detect temperature fluctuations, blood oxygen levels, breathing disturbances overnight and measure sleep quality. By pairing the watch with the app, it can also count your steps, calories burned, elevation and workout routes via the app.
The Withings ScanWatch Nova Brilliant will be available starting in early November. Those who want to purchase the watch in person can do so in the US, EU and UK at selected retailers. The new watch is priced at $600, €600 and £550, respectively, an identical price to the ScanWatch Nova.
Health technology is inching closer than ever to Star Trek’s sickbay. The Withings BeamO combines a digital thermometer, a stethoscope, a fingertip electrocardiogram, and a blood oxygen meter in one small gadget. It can help detect and track various health issues and upload and share data to your doctor. It’s expected to drop later in 2024 for around $250.
Aside from a brief on-again-off-again thing with Nokia, Withings has been quietly establishing itself as a home health powerhouse in recent years. The French company might not have the big-name pull of an Apple or Samsung, but it has been making some expertly crafted devices designed to make vital readings accessible outside the doctor’s office.
While the name suggests an ’80s toy manufacturer, BeamO looks to be one of the company’s more compelling healthcare offerings. It’s not a fitness watch or a sleep tracking pad, but rather a new category for Withings. The “multiscope,” as the company has deemed it, is designed to give patients easy access to vitals during teleconference health calls.
From that perspective, the product makes a lot of sense. According to the U.S. government, telehealth visits (understandably) skyrocketed 15x during the pandemic. While that number has no doubt regressed somewhat as the world has reopened, the relative ease and timeline versus an in-office visit for non-emergencies can’t really be debated.
Image Credits: Withings
“Smaller than a smartphone” per Withings’ description, the system offers four key health metrics. It’s kind of a supercharged digital thermometer that also serves as an electrocardiogram, oximeter and stethoscope, giving your healthcare provider more insight into what’s going on with you in real time.
“Post-pandemic telemedicine is commonplace,” notes CEO Eric Carrell. “While convenient and cost-effective, remote visits lacked the ability for health professionals to carry out the routine checks they perform in person. BeamO will make this possible remotely with a device that combines the functionality of four different pieces of medical equipment.”
The system is capable of reading SpO2, heart rate and ECG (“medical grade” says Withings) at once, displaying pertinent info on its display. Headphones can be connected to the system using a USB-C to audio jack adapter. That audio can also be sent to the healthcare provider via an app.
The system is still awaiting FDA clearance for things like AFib detection. Withings anticipates it will arrive on shelves this July for $250.
